NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development

(NYSE Amer.: NNVC) (the “Company”), a global leader in nanomedicines against viruses, announced today that it has completed the process of licensing the human Coronavirus field for drug development and commercialization from TheraCour Pharma, [전체본문 2021-09-14 20:07:00Z]